About this trial
The primary research objective of the project is to determine the role of eGC in microvascular reactivity in patients with coronary heart disease (CHD) before and after bypass grafting (cross-sectional study 2).The main objective of the project is to increase the excellence and interdisciplinarity of scientific work at MEFOS by connecting researchers from different scientific fields, improving conditions and resources for scientific work, and increasing international cooperation, in line with strategic objective 1: raising scientific excellence. The results of the project could provide pathophysiological insight into the development and maintenance of endothelial dysfunction in CVD, as well as identify new biomarkers for CVD.
Eligibility criteria
Qualifiers
adult patients of both sexes over 18 years of age
Caucasian
undergoing elective coronary artery bypass grafting (CABG)
provided written informed consent
Disqualifiers
emergency surgery
sepsis or severe systemic inflammation before surgery
severe renal or hepatic insufficiency
immunosuppression
Trial design
Treatments tested in this trial
- Not listed